HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Human brain sialoglycan ligand for CD33, a microglial inhibitory Siglec implicated in Alzheimer's disease.

Abstract
Alzheimer's disease (AD) is characterized by accumulation of misfolded proteins. Genetic studies implicate microglia, brain-resident phagocytic immune cells, in AD pathogenesis. As positive effectors, microglia clear toxic proteins, whereas as negative effectors, they release proinflammatory mediators. An imbalance of these functions contributes to AD progression. Polymorphisms of human CD33, an inhibitory microglial receptor, are linked to AD susceptibility; higher CD33 expression correlates with increased AD risk. CD33, also called Siglec-3, is a member of the sialic acid-binding immunoglobulin-type lectin (Siglec) family of immune regulatory receptors. Siglec-mediated inhibition is initiated by binding to complementary sialoglycan ligands in the tissue environment. Here, we identify a single sialoglycoprotein in human cerebral cortex that binds CD33 as well as Siglec-8, the most abundant Siglec on human microglia. The ligand, which we term receptor protein tyrosine phosphatase zeta (RPTPζ)S3L, is composed of sialylated keratan sulfate chains carried on a minor isoform/glycoform of RPTPζ (phosphacan) and is found in the extracellular milieu of the human brain parenchyma. Brains from human AD donors had twofold higher levels of RPTPζS3L than age-matched control donors, raising the possibility that RPTPζS3L overexpression limits misfolded protein clearance contributing to AD pathology. Mice express the same structure, a sialylated keratan sulfate RPTPζ isoform, that binds mouse Siglec-F and crossreacts with human CD33 and Siglec-8. Brains from mice engineered to lack RPTPζ, the sialyltransferase St3gal4, or the keratan sulfate sulfotransferase Chst1 lacked Siglec binding, establishing the ligand structure. The unique CD33 and Siglec-8 ligand, RPTPζS3L, may contribute to AD progression.
AuthorsAnabel Gonzalez-Gil, Ryan N Porell, Steve M Fernandes, Eila Maenpaa, T August Li, Tong Li, Philip C Wong, Kazuhiro Aoki, Michael Tiemeyer, Zaikuan J Yu, Benjamin C Orsburn, Namandjé N Bumpus, Russell T Matthews, Ronald L Schnaar
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 298 Issue 6 Pg. 101960 (06 2022) ISSN: 1083-351X [Electronic] United States
PMID35452678 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
Chemical References
  • CD33 protein, human
  • Ligands
  • Protein Isoforms
  • Sialic Acid Binding Ig-like Lectin 3
  • Sialic Acid Binding Immunoglobulin-like Lectins
  • Keratan Sulfate
  • Receptor-Like Protein Tyrosine Phosphatases, Class 5
Topics
  • Alzheimer Disease (genetics, metabolism)
  • Animals
  • Brain (metabolism)
  • Humans
  • Keratan Sulfate (metabolism)
  • Ligands
  • Mice
  • Microglia (metabolism)
  • Protein Isoforms (metabolism)
  • Receptor-Like Protein Tyrosine Phosphatases, Class 5 (metabolism)
  • Sialic Acid Binding Ig-like Lectin 3 (genetics, metabolism)
  • Sialic Acid Binding Immunoglobulin-like Lectins (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: